Immunicum’s Chief Scientific Officer presented the technology behind the cancer vaccine INTUVAX at a symposium at Karolinska Institutet in conjunction with world-leading researchers in immunology
March 13, 2015 04:06 ET
|
Immunicum AB
Gothenburg, Sweden, 2015-03-13 09:06 CET (GLOBE NEWSWIRE) --
Immunicum AB (publ) today announced that the Company's Chief Scientific Officer, Dr. Alex Karlsson-Parra, has presented the technology...
Immunicums forskningschef presenterade teknologin bakom cancervaccinet INTUVAX på en konferens på Karolinska Institutet tillsammans med världsledande forskare inom immunologi
March 13, 2015 04:06 ET
|
Immunicum AB
Göteborg, 2015-03-13 09:06 CET (GLOBE NEWSWIRE) --
Immunicum AB (publ) meddelade idag att Bolagets forskningschef, Dr. Alex Karlsson-Parra, presenterade teknologin bakom INTUVAX...
Immunicum: Halvårsrapport juli – december 2014
February 20, 2015 02:45 ET
|
Immunicum AB
Göteborg, 2015-02-20 08:45 CET (GLOBE NEWSWIRE) --
Andra halvåret 2014 jämfört med samma period 2013
Resultat
Resultatet för andra kvartalet, 1 oktober – 31 december 2014, uppgick till...
Immunicum receives approval to start phase II study with the therapeutic cancer vaccine INTUVAX
February 17, 2015 11:12 ET
|
Immunicum AB
Gothenburg, Sweden, 2015-02-17 17:12 CET (GLOBE NEWSWIRE) --
Immunicum AB (publ) today announced that the Swedish Medical Products Agency has granted the Company's application to commence a phase II...
Immunicum erhåller godkännande att starta fas II-studie med det terapeutiska cancervaccinet INTUVAX
February 17, 2015 11:12 ET
|
Immunicum AB
Göteborg, 2015-02-17 17:12 CET (GLOBE NEWSWIRE) --
Immunicum AB (publ) meddelade idag att Läkemedelsverket beviljat Bolagets ansökan om att starta en klinisk fas II-studie på patienter med...
Patent for the production of Immunicum’s therapeutic cancer vaccines to be granted in Europe
January 27, 2015 09:10 ET
|
Immunicum AB
Gothenburg, Sweden, 2015-01-27 15:10 CET (GLOBE NEWSWIRE) --
Immunicum AB (publ) today announced that the European Patent Office (EPO) has announced its intention to grant a patent pertaining to the...
Patentansökan avseende produktion av Immunicums terapeutiska cancervacciner kommer att beviljas i Europa
January 27, 2015 09:10 ET
|
Immunicum AB
Göteborg, 2015-01-27 15:10 CET (GLOBE NEWSWIRE) --
Immunicum AB (publ) rapporterade idag att det europeiska patentverket, European Patent Office (EPO), har meddelat att man avser bevilja en...
Immunicum: Patent application related to Immunicum’s therapeutic cancer vaccine SUBCUVAX to be granted in the US
December 19, 2014 02:30 ET
|
Immunicum AB
Gothenburg, Sweden, 2014-12-19 08:30 CET (GLOBE NEWSWIRE) --
Immunicum AB (publ) today announced that the US Patent and Trademark Office has declared its intention to approve the Company's patent...
Immunicum: Patentansökan kopplad till Immunicums terapeutiska cancervaccin SUBCUVAX kommer att beviljas i USA
December 19, 2014 02:30 ET
|
Immunicum AB
Göteborg, 2014-12-19 08:30 CET (GLOBE NEWSWIRE) --
Immunicum AB (publ) meddelade idag att det amerikanska patentverket aviserat sin avsikt att godkänna Bolagets patentansökan för en genetiskt...
Immunicum: The patent application relating to activation of Immunicum’s COMBIG-cells for therapeutic cancer vaccination will be granted in the US
December 15, 2014 03:04 ET
|
Immunicum AB
Gothenburg, Sweden, 2014-12-15 09:04 CET (GLOBE NEWSWIRE) --
Immunicum AB (publ) today announced that the United States Patent and Trademark Office (USPTO) has submitted a "Notice of Allowance"...